RxDoctor Payments Data
★ My doctorsLook up a doctor →

Farhad Amiri, DO

Psychiatry · Southfield, MINPI 1154703361

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $25,025 of the $39,739 with a category attached, or 63.0%. Axsome Therapeutics, Inc. accounts for 69.8% of it on its own, with 23 other manufacturers making up the rest. 2025 is the largest year on record at $29,522, more than ten times the $410 reported in 2019. Among psychiatry clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$39,739in general payments, 2019–2025

Across 453 payments — averaging $87.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$28K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
  • Otsuka America Pharmaceutical, Inc.$1K
  • AbbVie$1K
  • Alkermes, Inc.$1K
  • Neuronetics, Inc.$969
  • plus $5K from 18 others

What the payments were for

  • Speaking & faculty fees$25,02563%
  • Travel & lodging$5881%
  • Food & beverage$14,06935%
  • Education$570%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Axsome Therapeutics, Inc.60$27,732
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)76$2,338
Otsuka America Pharmaceutical, Inc.40$1,380
AbbVie48$1,339
Alkermes, Inc.32$1,236
Neuronetics, Inc.21$969
Neurocrine Biosciences, Inc.28$884
Supernus Pharmaceuticals, Inc.32$691
Lundbeck LLC28$492
Johnson & Johnson18$488
E.r. Squibb & Sons, L.L.C.9$345
Acadia Pharmaceuticals Inc4$334
Teva Pharmaceuticals USA, Inc.5$322
Takeda Pharmaceuticals U.S.A., Inc.12$218
Idorsia Pharmaceuticals US Inc6$216
Neos Therapeutics, LP10$168
Vanda Pharmaceuticals Inc.7$167
Noven Therapeutics, LLC7$143
Avanir Pharmaceuticals, Inc.1$115
Tris Pharma Inc4$72
Indivior Inc.2$35
Almatica Pharma LLC1$26
OWP Pharmaceuticals, Inc.1$16
AstraZeneca1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$39,739 in reported general payments places this provider in the 95th percentile of 1,166 psychiatry providers in Michigan.

See all psychiatry providers in Michigan →

Medicare billing

Part B allowed, 2024
$50,099
Medicare patients
124
Services billed
450

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Paliperidone ErPaliperidone13$4,163
Clozapine13$1,846
Clonazepam85$458
Haloperidol11$367
Lamotrigine69$364
Venlafaxine Hcl ErVenlafaxine Hcl18$305
Mirtazapine12$286
Lorazepam16$282
Quetiapine Fumarate23$223
Prazosin Hcl12$181
Benztropine Mesylate14$178
Hydroxyzine Hcl20$162
Trazodone Hcl34$150
Lithium Carbonate24$117
Escitalopram Oxalate16$94

Paid to pharmacies, not to this prescriber.

Other psychiatry in Southfield

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →